MedPath

Extracorporeal Shock Wave Lithotriptor Indicated for Fragmenting Urinary Stones in the Kidney

Phase 3
Conditions
Kidney Stones
Interventions
Device: LithoSpace Extracorporeal Shockwave Lithotripter
Registration Number
NCT00959153
Lead Sponsor
Advance Shockwave Technology GmbH
Brief Summary

A total of 20 subjects presenting with urinary stone(s) in the kidney or ureter will be treated with an extracorporeal shockwave lithotripsy device to fragment the stones. Subjects will be followed for 14 days. If at the 14 day follow-up visit the subject continues to present with a stone size 4 mm or greater will have an option of retreatment or other intervention. If the subject consents to be retreated at this time, this subject will be followed up for another 14 days.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Diagnosis of a solitary Urinary stones in the renal pelvis or renal calyces or ureter
  • Presence of one stone greater than 4 mm and less than 12 mm
Exclusion Criteria
  • Urinary tract obstruction, acute or unresolved cholecystitis, cholangitis, pancreatitis or obstruction of the biliary duct system
  • Impaction of stone to be treated
  • Staghorn stones
  • Failed or inadequate lithotripsy procedure within 3 months prior to study
  • Coagulation abnormalities or anticoagulation therapy
  • Pregnant or females of child-bearing potential General, spinal or epidural anesthesia is contraindicated
  • Can not be positioned correctly for fluoroscopic imaging

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Kidney stonesLithoSpace Extracorporeal Shockwave LithotripterKidney stones
Primary Outcome Measures
NameTimeMethod
stone fragmentation14 days
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Allied Urological Services, LLC

🇺🇸

New York, New York, United States

Metropolitan Lithotriptor Associates

🇺🇸

Garden City, New York, United States

© Copyright 2025. All Rights Reserved by MedPath